Freeline Therapeutics Holdings plc Quarterly Assets in USD from Q4 2019 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Freeline Therapeutics Holdings plc quarterly Assets history and growth rate from Q4 2019 to Q3 2023.
Freeline Therapeutics Holdings plc Assets for the quarter ending September 30, 2023 was $49.2M, a 50.8% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$49.2M	-$50.9M	-50.8%	Sep 30, 2023	6-K	2023-12-01
Q2 2023	$62.7M	-$99.5M	-61.4%	Jun 30, 2023	6-K	2023-08-15
Q1 2023	$81.4M	-$115M	-58.5%	Mar 31, 2023	6-K	2023-05-30
Q4 2022	$86.6M	-$54.5M	-38.6%	Dec 31, 2022	6-K	2023-12-01
Q3 2022	$100M	-$70.7M	-41.4%	Sep 30, 2022	6-K	2022-11-15
Q2 2022	$162M	-$38.9M	-19.4%	Jun 30, 2022	6-K	2022-08-09
Q1 2022	$196M	-$39.1M	-16.6%	Mar 31, 2022	6-K	2022-05-10
Q4 2021	$141M	-$127M	-47.5%	Dec 31, 2021	20-F	2023-04-04
Q3 2021	$171M			Sep 30, 2021	6-K	2021-11-09
Q2 2021	$201M	+$60.6M	+43.1%	Jun 30, 2021	6-K	2021-08-16
Q1 2021	$235M			Mar 31, 2021	6-K	2021-05-17
Q4 2020	$269M	+$171M	+176%	Dec 31, 2020	20-F	2022-03-31
Q2 2020	$140M			Jun 30, 2020	6-K	2020-10-29
Q4 2019	$97.4M			Dec 31, 2019	20-F	2021-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.